CHILDREN'S MUCINEX COUGH OTC
Generic Name and Formulations:
Dextromethorphan HBr 5mg, guaifenesin 100mg; per 5mL; cherry flavor; alcohol-free; contains sodium 3mg.
Indications for CHILDREN'S MUCINEX COUGH:
Chest congestion. Cough.
<4yrs: do not use. 4–5yrs: 2.5–5mL every 4 hours. 6–11yrs: 5–10mL every 4 hours. Max 6 doses/day.
During or within 14 days of MAOIs.
Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers. Mini-Melts: Renal disease. Magnesium-restricted diet.
Antitussive + expectorant.
Hypertensive crisis with MAOIs (see Contraindications).
GI upset, drowsiness, headache, rash.
DM—20, 40; Max Strength—14, 28; Pkts—12; Soln—4oz
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- New Romosozumab BLA Includes Data from Additional Osteoporosis Trials
- Impact of Maternal Diabetes on Outcomes in Very Preterm, Very Low-Birth-Weight Infants
- Age-Related Differences in Manifestation of Cushing Disease Identified